ArticleFrontiers in psychiatry2026
Predicting ordinal clinical outcomes in at-risk mental states: a multimodal approach.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Clinical outcomes in individuals with at-risk mental states (ARMS) are heterogeneous and extend beyond the simple dichotomy between transition and non-transition to psychosis. While previous studies have primarily focused on predicting the transition to psychosis, few have systematically examined multiple outcome stages, including remission and persistent subthreshold symptoms, using integrated neurobiological markers. This study aimed to identify the predictors of multilevel clinical outcomes in ARMS using a multimodal framework that incorporates clinical, functional, and electrophysiological measures. Methods: Eighty-seven subjects with ARMS were included and followed up, and the clinical outcomes were classified into four ordered categories based on a framework derived from the North American Prodrome Longitudinal Study 2 (NAPLS-2): remission, symptomatic, prodromal progression, and psychotic. Ordinal logistic regression analyses were conducted to identify predictors associated with ordered clinical outcomes using baseline measures as candidate predictors. Fifteen explanatory variables were used, including clinical symptoms, cognitive functioning, and electrophysiological measures [amplitudes and latencies of P300, duration mismatch negativity (dMMN), and frequency MMN (fMMN)]. Results: Reduced baseline dMMN amplitude, greater severity of attenuated positive symptoms indexed by unusual thought content, and poor cognitive functioning associated with daily living, assessed using the Schizophrenia Cognition Rating Scale, were independently associated with worse ordered clinical outcomes. Discussion: These findings suggest that future clinical trajectories of ARMS can be predicted by multimodal factors spanning neurophysiological, clinical, and functional domains. Early stratification of individuals at the ARMS stage may contribute to the development of personalized and stage-appropriate intervention strategies tailored to subsequent clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.